SCD and metabolic dysfunction-associated steatotic liver disease: The Srebp1c target gene Scd1, responsible for fatty acid desaturation, has been associated with NAFLD development [51], but its upregulation could also be beneficial as monounsaturated fatty acids prevent the negative effects of saturated fatty acids, such as apoptosis and NASH [52,53].